The STR Group has expanded its Pharmaceutical Division and is pleased to introduce Medicor Global to the Pharmaceutical world; a separate niche entity specifically dedicated to Pharmaceutical Recruitment.

The creation of Medicor Global reflects the company’s commitment to evolve as this specialist market dictates, and ensures clients continue to receive the very best contract and permanent recruitment solutions, tailored to their needs.

The company name ‘Medicor Global’, the logo and branding were all designed in-house, resulting in the development of a brand that truly represents this niche division. In support of this specialist division, a dedicated website has been developed by Strategies featuring the latest Pharmaceutical jobs and client services.

Medicor Global is built around people with a vast experience of the Pharmaceutical industry and specialist recruitment practice. The team specialise in the supply of mid to upper level Clinical, Medical and Regulatory professionals for Drug Discovery, Clinical Research and Development and Post Approval services within the Pharmaceutical, Animal Health and Consumer Industries and Healthcare Practice.

Medicor Global is led by Richard Kelly, who has extensive experience in Pharmaceutical recruitment with his forte lying within New Business Development and high level Clinical Operations and Regulatory Affairs placements on an international scale. The team, which continues to expand at a rapid rate, is adept in delivering efficient bespoke solutions on a global scale, regardless of requirements or project timelines.

Commenting on the launch of Medicor Global, Richard Crawley, CEO of STR said;

“We are very proud to launch this new division and are confident that Medicor Global will further strengthen the portfolio of services that STR offers its clients, particularly on an international scale.

Medicor Global represents our ambitions and drive and shows how we are continuing to evolve into a global leading recruitment organisation. This new division demonstrates STR’s commitment in investing into the group and our desire to build a larger group of companies dedicated to niche industries”

In order to view Medicor Global’s new website please visit –